In this episode Dr. Steve Perrin, CEO at the ALS Therapy Development Institute and Dr. Fernando Vieira, CSO at ALS TDI join us to talk about Antisense Oligonucleotides (ASOs). ASOs are molecules, mostly DNA, that are specifically designed to target and suppress the expression of a specific gene. They work by binding directly to messenger RNA (mRNA) and block it from producing a specific protein.

Access all episodes of the Endpoints Podcast.

Support the show.